These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6804257

  • 1. The prevention of alloxan-induced diabetes in mice by the iron-chelator detapac: suggestion of a role for iron in the cytotoxic process.
    Heikkila RE, Cabbat FS.
    Experientia; 1982 Mar 15; 38(3):378-9. PubMed ID: 6804257
    [Abstract] [Full Text] [Related]

  • 2. Opposite effects of two metal-chelators on alloxan-induced diabetes in mice.
    Grankvist K, Marklund SL.
    Life Sci; 1983 Dec 19; 33(25):2535-40. PubMed ID: 6645812
    [Abstract] [Full Text] [Related]

  • 3. The prevention of alloxan-induced diabetes by the immunosuppressive agent azathioprine.
    Heikkila RE, Cabbat FS.
    Res Commun Chem Pathol Pharmacol; 1981 Jan 19; 31(1):163-71. PubMed ID: 7196067
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice.
    el-Hage A, Herman EH, Yang GC, Crouch RK, Ferrans VJ.
    Res Commun Chem Pathol Pharmacol; 1986 Jun 19; 52(3):341-60. PubMed ID: 3090662
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protection against alloxan-induced diabetes by various urea derivatives: relationship between protective effects and reactivity with the hydroxyl radical.
    Tibaldi J, Benjamin J, Cabbat FS, Heikkila RE.
    J Pharmacol Exp Ther; 1979 Nov 19; 211(2):415-8. PubMed ID: 501570
    [Abstract] [Full Text] [Related]

  • 7. 1,10 phenanthroline, a metal chelator, protects against alloxan- but not streptozotocin-induced diabetes.
    Eizirik DL, de Lúcio MA, Boschero AC, Hoffmann ME.
    J Free Radic Biol Med; 1986 Nov 19; 2(3):189-92. PubMed ID: 3033047
    [Abstract] [Full Text] [Related]

  • 8. Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
    El-Hage AN, Herman EH, Ferrans VJ.
    Res Commun Chem Pathol Pharmacol; 1981 Sep 19; 33(3):509-23. PubMed ID: 7036302
    [Abstract] [Full Text] [Related]

  • 9. Involvement of blood glucose in the dimethylthiourea-induced protection against alloxan-induced diabetes.
    Masukawa T, Nakanishi K.
    Jpn J Pharmacol; 1994 Sep 19; 66(1):159-61. PubMed ID: 7861663
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of protection from alloxan diabetes provided by n-butanol.
    Schauberger CW, Thies RL, Fischer LJ.
    J Pharmacol Exp Ther; 1977 May 19; 201(2):450-5. PubMed ID: 323464
    [Abstract] [Full Text] [Related]

  • 12. [Inhibition of diabetogenic effect of alloxan by intraperitoneal administration of glucose in mice].
    Ratsimamanga AR, Chirvan-Nia P, Bibal-Prot P.
    C R Acad Hebd Seances Acad Sci D; 1970 Aug 10; 271(6):599-602. PubMed ID: 4989914
    [No Abstract] [Full Text] [Related]

  • 13. Protective effects of gamma-hydroxybutyrate on alloxan induced diabetes in mice.
    Pierrefiche G, Topall G, Henriet I, Laborit H.
    Res Commun Chem Pathol Pharmacol; 1991 Mar 10; 71(3):309-19. PubMed ID: 2047574
    [Abstract] [Full Text] [Related]

  • 14. Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate.
    Heikkila RE, Winston B, Cohen G.
    Biochem Pharmacol; 1976 May 01; 25(9):1085-92. PubMed ID: 773385
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of diphenylhydantoin on the diabetogenic action of alloxan in the mouse.
    Mennear JH, Gossel TA.
    Diabetes; 1972 Feb 01; 21(2):80-3. PubMed ID: 5060107
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ferritin stimulation of hydroxyl radical production by rat liver nuclei.
    Kukiełka E, Cederbaum AI.
    Arch Biochem Biophys; 1994 Jan 01; 308(1):70-7. PubMed ID: 8311476
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Substitution reactions of iron-bleomycin-DNA with EDTA, detapac or desferrioxamine.
    Aronovitch J, Godinger D, Goldstein S, Czapski G.
    J Antibiot (Tokyo); 1987 Sep 01; 40(9):1344-8. PubMed ID: 2445723
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.